Andy Harrison
| Andy Harrison | |
|---|---|
| Born | Andrew Harrison |
| 🎓 Alma mater | McGill University, Cornell University |
| 💼 Occupation | Investor, CEO |
| Known for | S32, X Development, Verily |
Andy Harrison is an investor and the General Partner & CEO of S32; a venture capital firm investing at the frontiers of technology. He has also notably worked at Alphabet's X (Google X) and Verily (Google Life Sciences), and has made significant contributions to the technology sector.[1][2]
Early life and education[edit]
Andy Harrison holds an Undergraduate Degree in Biochemical Engineering from McGill University and a Master's in Biomedical Engineering from Cornell University. In addition, he has earned the Chartered Financial Analyst designation.[3]
Career[edit]
Andy started his professional career at RBC Ventures, a fund that was part of the DFJ Global Network. From there, he helped build and scale two companies, one seeded by Stanford University’s Endowment, which was successfully acquired.[4]
At Google, he took on commercial leadership roles at X (Google X) and Verily (Google Life Sciences). As an executive at Google X, Andy contributed to projects involving artificial intelligence, machine learning, quantum computing, and cybersecurity. He also played a key role in spinning out the AI and quantum computing team Sandbox and the AI and robotic software team Intrinsic.[5][6]
Andy Harrison became a General Partner of S32 in 2021, and was named CEO of the venture capital firm in 2022. Andy's experience at Alphabet and his expertise in AI, machine learning, and life sciences guided S32 to identify and support major innovations.[7][8][9]
His investments have fostered successful ventures such as Cohere, Ema, Inceptive, InWorld, Bighat Biosciences, Scale, and Gretel Labs, among others.[10][11]
Personal Life[edit]
Andy Harrison is an speaker at industry conferences and universities. His expertise in artificial intelligence has made him a sought-after voice in mainstream publications such as The Wall Street Journal, Bloomberg, Reuters, CNBC, and TechCrunch.[12]
Patents[edit]
Andy holds multiple patents in several fields, including:
- Cell Culture System EU 1,820,846.
- Devices and Methods for Pharmacokinetic-Based Cell Culture System US 7,288,405, 8,030,061US 7,288,405, 8,030,061.
- Pharmacokinetic-based Culture System with Biological BarriersPharmacokinetic-based Culture System with Biological Barriers US 11/436,100.
References[edit]
- ↑ https://techcrunch.com/2023/10/05/section-32-closes-on-525m-fund-says-there-is-a-zone-of-commoditization-that-you-have-to-avoid-while-investing-in-ai/
- ↑ https://fortune.com/2024/03/27/google-andy-conrad-harrison-reunited-vc-firm-s32-ai/
- ↑ https://www.washingtonpost.com/technology/2023/08/05/ai-hype-bubble-chatgpt/
- ↑ https://fortune.com/2024/09/30/sam-altman-openai-equity-stake-billionaire/
- ↑ https://fortune.com/2024/03/27/google-andy-conrad-harrison-reunited-vc-firm-s32-ai/
- ↑ https://techcrunch.com/2024/09/13/first-impressions-of-openai-o1-an-ai-designed-to-overthink-it/
- ↑ https://techcrunch.com/2023/10/05/section-32-closes-on-525m-fund-says-there-is-a-zone-of-commoditization-that-you-have-to-avoid-while-investing-in-ai/
- ↑ https://fortune.com/2024/03/27/google-andy-conrad-harrison-reunited-vc-firm-s32-ai/
- ↑ https://www.reuters.com/business/finance/ai-deals-lift-us-venture-capital-funding-highest-level-two-years-data-shows-2024-07-03/
- ↑ https://fortune.com/2024/09/30/sam-altman-openai-equity-stake-billionaire/
- ↑ https://www.washingtonpost.com/technology/2023/08/05/ai-hype-bubble-chatgpt/
- ↑ https://techcrunch.com/2023/10/05/section-32-closes-on-525m-fund-says-there-is-a-zone-of-commoditization-that-you-have-to-avoid-while-investing-in-ai/
This article "Andy Harrison (investor)" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Andy Harrison (investor). Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
